Home/Filings/4/0001209191-23-003466
4//SEC Filing

Stark Charles William 4

Accession 0001209191-23-003466

CIK 0000822370other

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 2:32 PM ET

Size

5.7 KB

Accession

0001209191-23-003466

Insider Transaction Report

Form 4
Period: 2023-01-12
Stark Charles William
SVP, Clinical Development
Transactions
  • Award

    Options

    2023-01-12$4.50/sh+100,000$450,000100,000 total
    Exercise: $4.50Exp: 2033-01-11Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The options vest as to one-third of the option shares on the 12-month anniversary of the grant date and as to the remaining two-thirds of the option shares in 24 equal monthly installments as of the end of each month after such anniversary.

Issuer

Emmaus Life Sciences, Inc.

CIK 0000822370

Entity typeother

Related Parties

1
  • filerCIK 0001901666

Filing Metadata

Form type
4
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 2:32 PM ET
Size
5.7 KB